Microbial Etiologies of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) can be caused by a wide variety of bacteria that originate from the patient flora or the health care environment. We review the medical and microbiology literature and the results of the SENTRY Antimicr...
Saved in:
| Published in | Clinical infectious diseases Vol. 51; no. Supplement-1; pp. S81 - S87 |
|---|---|
| Main Author | |
| Format | Journal Article Conference Proceeding |
| Language | English |
| Published |
Oxford
The University of Chicago Press
01.08.2010
University of Chicago Press Oxford University Press |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1058-4838 1537-6591 1537-6591 |
| DOI | 10.1086/653053 |
Cover
| Abstract | Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) can be caused by a wide variety of bacteria that originate from the patient flora or the health care environment. We review the medical and microbiology literature and the results of the SENTRY Antimicrobial Surveillance Program (1997-2008) to establish the pathogens most likely to cause HABP or VABP. In all studies, a consistent 6 organisms (Staphylococcus aureus [28.0%], Pseudomonas aeruginosa [21.8%], Klebsiella species [9.8%], Escherichia coli [6.9%], Acinetobacter species [6.8%], and Enterobacter species [6.3%]) caused ∼80% of episodes, with lower prevalences of Serratia species, Stenotrophomonas maltophilia, and community-acquired pathogens, such as pneumococci and Haemophilus influenzae. Slight changes in the pathogen order were noted among geographic regions; Latin America had an increased incidence of nonfermentative gram-negative bacilli. In addition, VABP isolates of the same species had a mean of 5%-10% less susceptibility to frequently used extended-spectrum antimicrobials, and the rate of drug resistance among HABP and VABP pathogens has been increasing by 1% per year (2004-2008). In conclusion, the empirical treatment of HABP and VABP due to prevailing bacterial causes and emerging drug resistance has become more challenging and requires use of multidrug empirical treatment regimens for routine clinical practice. These facts have profound impact on the choices of comparison therapies to be applied in contemporary new drug clinical trials for pneumonia. |
|---|---|
| AbstractList | Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) can be caused by a wide variety of bacteria that originate from the patient flora or the health care environment. We review the medical and microbiology literature and the results of the SENTRY Antimicrobial Surveillance Program (1997-2008) to establish the pathogens most likely to cause HABP or VABP. In all studies, a consistent 6 organisms (Staphylococcus aureus [28.0%], Pseudomonas aeruginosa [21.8%], Klebsiella species [9.8%], Escherichia coli [6.9%], Acinetobacter species [6.8%], and Enterobacter species [6.3%]) caused 80% of episodes, with lower prevalences of Serratia species, Stenotrophomonas maltophilia, and community-acquired pathogens, such as pneumococci and Haemophilus influenzae. Slight changes in the pathogen order were noted among geographic regions; Latin America had an increased incidence of nonfermentative gram-negative bacilli. In addition, VABP isolates of the same species had a mean of 5%-10% less susceptibility to frequently used extended- spectrum antimicrobials, and the rate of drug resistance among HABP and VABP pathogens has been increasing by 1% per year (2004-2008). In conclusion, the empirical treatment of HABP and VABP due to prevailing bacterial causes and emerging drug resistance has become more challenging and requires use of multidrug empirical treatment regimens for routine clinical practice. These facts have profound impact on the choices of comparison therapies to be applied in contemporary new drug clinical trials for pneumonia. [PUBLICATION ABSTRACT] Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) can be caused by a wide variety of bacteria that originate from the patient flora or the health care environment. We review the medical and microbiology literature and the results of the SENTRY Antimicrobial Surveillance Program (1997-2008) to establish the pathogens most likely to cause HABP or VABP. In all studies, a consistent 6 organisms (Staphylococcus aureus [28.0%], Pseudomonas aeruginosa [21.8%], Klebsiella species [9.8%], Escherichia coli [6.9%], Acinetobacter species [6.8%], and Enterobacter species [6.3%]) caused approximately 80% of episodes, with lower prevalences of Serratia species, Stenotrophomonas maltophilia, and community-acquired pathogens, such as pneumococci and Haemophilus influenzae. Slight changes in the pathogen order were noted among geographic regions; Latin America had an increased incidence of nonfermentative gram-negative bacilli. In addition, VABP isolates of the same species had a mean of 5%-10% less susceptibility to frequently used extended-spectrum antimicrobials, and the rate of drug resistance among HABP and VABP pathogens has been increasing by 1% per year (2004-2008). In conclusion, the empirical treatment of HABP and VABP due to prevailing bacterial causes and emerging drug resistance has become more challenging and requires use of multidrug empirical treatment regimens for routine clinical practice. These facts have profound impact on the choices of comparison therapies to be applied in contemporary new drug clinical trials for pneumonia. Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) can be caused by a wide variety of bacteria that originate from the patient flora or the health care environment. We review the medical and microbiology literature and the results of the SENTRY Antimicrobial Surveillance Program (1997-2008) to establish the pathogens most likely to cause HABP or VABP. In all studies, a consistent 6 organisms (Staphylococcus aureus [28.0%], Pseudomonas aeruginosa [21.8%], Klebsiella species [9.8%], Escherichia coli [6.9%], Acinetobacter species [6.8%], and Enterobacter species [6.3%]) caused ∼80% of episodes, with lower prevalences of Serratia species, Stenotrophomonas maltophilia, and community-acquired pathogens, such as pneumococci and Haemophilus influenzae. Slight changes in the pathogen order were noted among geographic regions; Latin America had an increased incidence of nonfermentative gram-negative bacilli. In addition, VABP isolates of the same species had a mean of 5%-10% less susceptibility to frequently used extended-spectrum antimicrobials, and the rate of drug resistance among HABP and VABP pathogens has been increasing by 1% per year (2004-2008). In conclusion, the empirical treatment of HABP and VABP due to prevailing bacterial causes and emerging drug resistance has become more challenging and requires use of multidrug empirical treatment regimens for routine clinical practice. These facts have profound impact on the choices of comparison therapies to be applied in contemporary new drug clinical trials for pneumonia. Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) can be caused by a wide variety of bacteria that originate from the patient flora or the health care environment. We review the medical and microbiology literature and the results of the SENTRY Antimicrobial Surveillance Program (1997-2008) to establish the pathogens most likely to cause HABP or VABP. In all studies, a consistent 6 organisms (Staphylococcus aureus [28.0%], Pseudomonas aeruginosa [21.8%], Klebsiella species [9.8%], Escherichia coli [6.9%], Acinetobacter species [6.8%], and Enterobacter species [6.3%]) caused approximately 80% of episodes, with lower prevalences of Serratia species, Stenotrophomonas maltophilia, and community-acquired pathogens, such as pneumococci and Haemophilus influenzae. Slight changes in the pathogen order were noted among geographic regions; Latin America had an increased incidence of nonfermentative gram-negative bacilli. In addition, VABP isolates of the same species had a mean of 5%-10% less susceptibility to frequently used extended-spectrum antimicrobials, and the rate of drug resistance among HABP and VABP pathogens has been increasing by 1% per year (2004-2008). In conclusion, the empirical treatment of HABP and VABP due to prevailing bacterial causes and emerging drug resistance has become more challenging and requires use of multidrug empirical treatment regimens for routine clinical practice. These facts have profound impact on the choices of comparison therapies to be applied in contemporary new drug clinical trials for pneumonia.Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) can be caused by a wide variety of bacteria that originate from the patient flora or the health care environment. We review the medical and microbiology literature and the results of the SENTRY Antimicrobial Surveillance Program (1997-2008) to establish the pathogens most likely to cause HABP or VABP. In all studies, a consistent 6 organisms (Staphylococcus aureus [28.0%], Pseudomonas aeruginosa [21.8%], Klebsiella species [9.8%], Escherichia coli [6.9%], Acinetobacter species [6.8%], and Enterobacter species [6.3%]) caused approximately 80% of episodes, with lower prevalences of Serratia species, Stenotrophomonas maltophilia, and community-acquired pathogens, such as pneumococci and Haemophilus influenzae. Slight changes in the pathogen order were noted among geographic regions; Latin America had an increased incidence of nonfermentative gram-negative bacilli. In addition, VABP isolates of the same species had a mean of 5%-10% less susceptibility to frequently used extended-spectrum antimicrobials, and the rate of drug resistance among HABP and VABP pathogens has been increasing by 1% per year (2004-2008). In conclusion, the empirical treatment of HABP and VABP due to prevailing bacterial causes and emerging drug resistance has become more challenging and requires use of multidrug empirical treatment regimens for routine clinical practice. These facts have profound impact on the choices of comparison therapies to be applied in contemporary new drug clinical trials for pneumonia. |
| Author | Jones, Ronald N. |
| Author_xml | – sequence: 1 givenname: Ronald N. surname: Jones fullname: Jones, Ronald N. |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23037658$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20597676$$D View this record in MEDLINE/PubMed |
| BookMark | eNqN0l1rFDEUBuAgFfuh_gNlENQbR5PJ5OtyLdUVKhatsngTzmQyku1ssk0yoP_e1FmrVEGvEngfDgnvOUR7PniL0H2CnxMs-QvOKGb0FjogjIqaM0X2yh0zWbeSyn10mNIaY0IkZnfQfoOZElzwA3Tx1pkYOgdjdZJdGMMXZ1MVhmoZ0tZlGOuFuZxctH31Eky28UqeeTttgndQge-rT9ZnN0IOsV6kFIyD_Hd9F90eYEz23u48Qh9fnZwfL-vTd6_fHC9Oa8OYyHWrQDWN4pxaYsBy6EB0WALvJVdUdEQoObSGNoKKRmCpLBt6GGSv-n7AoqVH6Ok8dxvD5WRT1huXjB1H8DZMSSvctooSSf5LSiJV808pWoWbhrW8yEc35DpM0ZcPa45FIfTHuIc7NHUb2-ttdBuI3_TPYgp4vAOQDIxDBG9c-uUopoIzWdyT2ZUWU4p2uCYE66vN0PNmFPjsBjSl3lK5zxHc-Cd_MPN1KsX-9j7BsOC45PWcu5Tt1-sc4oXmpReml6vPerXi5--XH840pd8B97bPnw |
| CODEN | CIDIEL |
| CitedBy_id | crossref_primary_10_3390_ph15121498 crossref_primary_10_1128_aac_00563_22 crossref_primary_10_3390_antibiotics11081100 crossref_primary_10_1016_j_cll_2014_02_004 crossref_primary_10_1080_23120053_2017_1313933 crossref_primary_10_1177_2292550319826098 crossref_primary_10_1128_AAC_01350_17 crossref_primary_10_1186_1471_2334_14_252 crossref_primary_10_1371_journal_pone_0089984 crossref_primary_10_1016_j_genrep_2025_102197 crossref_primary_10_1016_j_foodchem_2024_139045 crossref_primary_10_2174_1872208316666220512121205 crossref_primary_10_1002_jcph_566 crossref_primary_10_1016_j_diagmicrobio_2012_12_012 crossref_primary_10_2217_fmb_14_111 crossref_primary_10_1128_aac_02022_21 crossref_primary_10_1177_0885066616686052 crossref_primary_10_1080_14737159_2022_2018302 crossref_primary_10_1128_IAI_00464_15 crossref_primary_10_2196_57334 crossref_primary_10_1042_BCJ20160470 crossref_primary_10_1097_MCP_0b013e32835f27be crossref_primary_10_1021_acschembio_0c00554 crossref_primary_10_1016_j_jmii_2018_11_004 crossref_primary_10_1128_CMR_00017_11 crossref_primary_10_3390_idr13020038 crossref_primary_10_1073_pnas_1406763111 crossref_primary_10_1128_AAC_02183_13 crossref_primary_10_7759_cureus_51246 crossref_primary_10_3390_ijms241713393 crossref_primary_10_1097_MCP_0000000000000042 crossref_primary_10_3390_ijms17122120 crossref_primary_10_1007_s00408_015_9759_x crossref_primary_10_1002_cpt_2214 crossref_primary_10_1099_jmm_0_000730 crossref_primary_10_1128_AAC_01899_20 crossref_primary_10_1016_j_bcab_2019_101139 crossref_primary_10_1016_j_jiac_2021_03_010 crossref_primary_10_1126_scitranslmed_aad9922 crossref_primary_10_1016_j_exger_2013_12_010 crossref_primary_10_36290_int_2017_035 crossref_primary_10_1007_s40262_018_0705_y crossref_primary_10_1111_ijcp_13872 crossref_primary_10_1371_journal_pone_0143692 crossref_primary_10_1007_s40262_017_0623_4 crossref_primary_10_55262_fabadeczacilik_1099287 crossref_primary_10_3109_00365548_2013_871644 crossref_primary_10_1080_14656566_2019_1617852 crossref_primary_10_1016_j_irbm_2018_10_002 crossref_primary_10_1084_jem_20131471 crossref_primary_10_1055_s_0041_1740109 crossref_primary_10_1016_j_jmii_2013_09_005 crossref_primary_10_4236_ijcm_2015_610104 crossref_primary_10_1080_17425247_2017_1252329 crossref_primary_10_1016_j_cmi_2018_08_004 crossref_primary_10_2217_fmb_15_144 crossref_primary_10_1016_j_ajem_2016_10_058 crossref_primary_10_1080_08927014_2021_1874942 crossref_primary_10_1016_j_ijantimicag_2023_106886 crossref_primary_10_1007_s10096_015_2551_2 crossref_primary_10_1099_jmm_0_066043_0 crossref_primary_10_1038_s41598_019_55601_0 crossref_primary_10_1007_s00436_022_07609_1 crossref_primary_10_1111_j_1758_2229_2011_00254_x crossref_primary_10_3390_healthcare10122546 crossref_primary_10_4103_ejb_ejb_43_18 crossref_primary_10_1128_mBio_00224_11 crossref_primary_10_4049_jimmunol_1701782 crossref_primary_10_1586_eri_12_81 crossref_primary_10_1016_j_coph_2017_10_009 crossref_primary_10_1016_j_jinf_2015_06_002 crossref_primary_10_1055_s_0041_1740335 crossref_primary_10_3390_antibiotics13030258 crossref_primary_10_1378_chest_11_1499 crossref_primary_10_1128_AAC_02356_19 crossref_primary_10_3389_fcimb_2023_1150658 crossref_primary_10_1016_j_toxicon_2022_09_004 crossref_primary_10_1111_j_1399_3062_2011_00710_x crossref_primary_10_3892_ijfn_2020_8 crossref_primary_10_1016_S0304_5412_14_70769_3 crossref_primary_10_1007_s10156_012_0509_1 crossref_primary_10_1016_j_vacune_2023_02_005 crossref_primary_10_1128_AAC_02388_15 crossref_primary_10_1007_s10096_017_3050_4 crossref_primary_10_1038_s41434_018_0022_y crossref_primary_10_24304_kjcp_2018_28_3_167 crossref_primary_10_3389_fmicb_2017_02276 crossref_primary_10_5812_jjm_2356 crossref_primary_10_1097_MD_0000000000022757 crossref_primary_10_1097_SHK_0000000000000507 crossref_primary_10_1128_Spectrum_01176_21 crossref_primary_10_1152_ajplung_00441_2022 crossref_primary_10_1016_j_drup_2024_101137 crossref_primary_10_1007_s00203_020_01818_x crossref_primary_10_3389_fvets_2019_00354 crossref_primary_10_3389_fmicb_2023_1280026 crossref_primary_10_1016_S1473_3099_17_30747_8 crossref_primary_10_1186_s13613_015_0061_0 crossref_primary_10_1002_14651858_CD007720_pub3 crossref_primary_10_4046_trd_2012_73_1_32 crossref_primary_10_1007_s00018_024_05472_0 crossref_primary_10_2147_IJN_S486450 crossref_primary_10_1016_j_jiac_2022_04_027 crossref_primary_10_1128_AAC_02377_19 crossref_primary_10_3390_md22040142 crossref_primary_10_3390_pathogens10091097 crossref_primary_10_3390_microorganisms9051083 crossref_primary_10_1093_jac_dkw510 crossref_primary_10_3390_antibiotics8010027 crossref_primary_10_1186_s13054_022_04204_9 crossref_primary_10_1080_21505594_2022_2051313 crossref_primary_10_1016_j_virusres_2022_198751 crossref_primary_10_1128_AAC_01922_18 crossref_primary_10_1007_s00284_022_03159_y crossref_primary_10_1097_MD_0000000000025440 crossref_primary_10_1093_cid_cit615 crossref_primary_10_17116_labs2019801173 crossref_primary_10_1007_s40121_020_00343_0 crossref_primary_10_1016_j_ijantimicag_2016_01_004 crossref_primary_10_1111_cbdd_14003 crossref_primary_10_1099_mgen_0_001271 crossref_primary_10_3892_etm_2017_4631 crossref_primary_10_1016_j_medine_2016_01_003 crossref_primary_10_1080_00405000_2020_1797263 crossref_primary_10_4103_0970_2113_99248 crossref_primary_10_1128_AAC_01020_16 crossref_primary_10_1080_14656566_2018_1559820 crossref_primary_10_1016_j_resinv_2019_03_001 crossref_primary_10_3390_microorganisms12040684 crossref_primary_10_3389_fmicb_2015_00038 crossref_primary_10_1007_s42770_021_00465_8 crossref_primary_10_1155_2021_9958281 crossref_primary_10_1186_s13756_019_0660_x crossref_primary_10_1038_s41522_019_0098_1 crossref_primary_10_1093_infdis_jiy438 crossref_primary_10_1007_s12325_016_0293_x crossref_primary_10_17352_ojps_000041 crossref_primary_10_1016_j_jtcme_2019_02_006 crossref_primary_10_1002_14651858_CD013864 crossref_primary_10_1080_14656566_2020_1739269 crossref_primary_10_1371_journal_pone_0229393 crossref_primary_10_3390_antibiotics13050400 crossref_primary_10_1111_jam_13728 crossref_primary_10_1016_j_rppneu_2014_01_002 crossref_primary_10_1186_1471_2377_11_110 crossref_primary_10_1007_s10311_021_01274_z crossref_primary_10_1177_23247096231222414 crossref_primary_10_1128_IAI_01822_14 crossref_primary_10_1007_s00105_014_3523_7 crossref_primary_10_1517_14656566_2014_889115 crossref_primary_10_1007_s13546_013_0679_6 crossref_primary_10_1007_s15010_021_01602_z crossref_primary_10_1371_journal_pone_0057634 crossref_primary_10_1186_s13054_016_1197_5 crossref_primary_10_3389_fmicb_2022_891807 crossref_primary_10_1128_AAC_02461_20 crossref_primary_10_1371_journal_pone_0175552 crossref_primary_10_1007_s40719_017_0094_y crossref_primary_10_1097_QCO_0000000000000713 crossref_primary_10_1016_j_jinf_2018_04_002 crossref_primary_10_1128_MRA_00417_19 crossref_primary_10_1016_j_jhin_2024_02_029 crossref_primary_10_1097_SLA_0000000000006409 crossref_primary_10_3390_ijms222111459 crossref_primary_10_1186_1471_2334_12_209 crossref_primary_10_1021_acssensors_0c01618 crossref_primary_10_1152_ajplung_00325_2021 crossref_primary_10_1186_s13756_019_0475_9 crossref_primary_10_1016_j_hazadv_2023_100232 crossref_primary_10_1093_ofid_ofz476 crossref_primary_10_1016_j_diagmicrobio_2014_11_005 crossref_primary_10_1088_1752_7163_ab2225 crossref_primary_10_1038_s41522_024_00483_y crossref_primary_10_1186_s13054_020_03067_2 crossref_primary_10_1016_j_diagmicrobio_2020_115100 crossref_primary_10_1128_JCM_02409_12 crossref_primary_10_1016_j_jiac_2017_03_010 crossref_primary_10_1142_S2591722619400015 crossref_primary_10_1039_D4LC00117F crossref_primary_10_1371_journal_pone_0016963 crossref_primary_10_1371_journal_pone_0054162 crossref_primary_10_7759_cureus_8573 crossref_primary_10_1128_mBio_00975_20 crossref_primary_10_20473_ijtid_v7i5_5737 crossref_primary_10_1099_jmm_0_032516_0 crossref_primary_10_1111_jphp_13156 crossref_primary_10_1093_cid_ciab032 crossref_primary_10_1016_j_diagmicrobio_2020_115236 crossref_primary_10_1186_s12931_022_02253_w crossref_primary_10_24304_kjcp_2017_27_4_207 crossref_primary_10_3390_jpm14030328 crossref_primary_10_1016_j_ijantimicag_2012_02_010 crossref_primary_10_1016_j_vacun_2022_11_001 crossref_primary_10_1128_IAI_02904_14 crossref_primary_10_1111_cmi_12176 crossref_primary_10_3390_microorganisms11102420 crossref_primary_10_5812_archcid_136159 crossref_primary_10_1002_mlf2_12135 crossref_primary_10_1128_mBio_01976_16 crossref_primary_10_3389_fmicb_2017_01576 crossref_primary_10_1002_jcph_1733 crossref_primary_10_1016_j_jiph_2016_11_016 crossref_primary_10_36290_vnl_2017_149 crossref_primary_10_1016_j_jcv_2016_04_008 crossref_primary_10_3109_00365548_2011_645504 crossref_primary_10_3390_jcm9010275 crossref_primary_10_1007_s00431_020_03675_8 crossref_primary_10_1016_j_diagmicrobio_2016_08_005 crossref_primary_10_1111_j_1574_6976_2011_00290_x crossref_primary_10_1111_eva_12085 crossref_primary_10_3390_microorganisms9112333 crossref_primary_10_1016_j_jiph_2019_01_057 crossref_primary_10_1016_j_jiph_2016_04_016 crossref_primary_10_1161_STROKEAHA_117_020250 crossref_primary_10_1128_genomeA_01118_17 crossref_primary_10_1128_MMBR_00078_15 crossref_primary_10_1016_j_jiac_2022_02_012 crossref_primary_10_1093_clinchem_hvab143 crossref_primary_10_3389_fmicb_2024_1508030 crossref_primary_10_1080_14787210_2018_1441024 crossref_primary_10_54393_pjhs_v3i05_229 crossref_primary_10_1007_s00063_018_0494_y crossref_primary_10_1186_s42269_020_00305_z crossref_primary_10_1038_s43586_022_00190_y crossref_primary_10_1016_j_vhri_2014_03_002 crossref_primary_10_1093_jac_dkr101 crossref_primary_10_1186_s12879_025_10549_7 crossref_primary_10_1111_nicc_13227 crossref_primary_10_2147_IDR_S419699 crossref_primary_10_1111_mmi_14434 crossref_primary_10_1007_s12013_014_0208_x crossref_primary_10_1016_j_ijbiomac_2024_136976 crossref_primary_10_1186_s12879_019_3770_4 crossref_primary_10_3390_microorganisms9061282 crossref_primary_10_1093_ofid_ofz149 crossref_primary_10_1073_pnas_1501049112 crossref_primary_10_3390_diagnostics15030265 crossref_primary_10_1128_AAC_04839_14 crossref_primary_10_4103_ijmm_IJMM_16_430 crossref_primary_10_1111_evo_12909 crossref_primary_10_1097_CCM_0000000000000972 crossref_primary_10_1002_jcb_27373 crossref_primary_10_1016_j_ijid_2013_02_004 crossref_primary_10_1111_crj_13612 crossref_primary_10_1128_spectrum_01517_23 crossref_primary_10_1093_infdis_jiw405 crossref_primary_10_3389_fimmu_2020_00091 crossref_primary_10_1080_23744235_2017_1361546 crossref_primary_10_1165_rcmb_2014_0195OC crossref_primary_10_1093_jac_dkab494 crossref_primary_10_1016_j_msec_2019_03_061 crossref_primary_10_1016_j_hrtlng_2015_01_010 crossref_primary_10_3390_antibiotics10081000 crossref_primary_10_3390_ijms17010064 crossref_primary_10_3349_ymj_2011_52_5_793 crossref_primary_10_4315_0362_028X_JFP_16_168 crossref_primary_10_1371_journal_pone_0170033 crossref_primary_10_1002_ccr3_6997 crossref_primary_10_1007_s00134_023_07210_9 crossref_primary_10_1007_s00134_013_2828_9 crossref_primary_10_1080_1120009X_2020_1785741 crossref_primary_10_1152_ajplung_00046_2014 crossref_primary_10_2146_ajhp170056 crossref_primary_10_5897_AJMR2016_8048 crossref_primary_10_1089_mdr_2020_0162 crossref_primary_10_1016_j_jhin_2020_09_036 crossref_primary_10_1126_scitranslmed_aba0501 crossref_primary_10_1016_j_clinthera_2014_06_029 crossref_primary_10_1186_s12866_020_1702_5 crossref_primary_10_1007_s00134_013_3025_6 crossref_primary_10_1371_journal_pone_0231625 crossref_primary_10_3390_ijms22083858 crossref_primary_10_1089_sur_2013_156 crossref_primary_10_1007_s00134_014_3564_5 crossref_primary_10_1128_JB_06632_11 crossref_primary_10_1186_s12890_021_01773_3 crossref_primary_10_1371_journal_pone_0148222 crossref_primary_10_3389_fcimb_2022_934671 crossref_primary_10_1080_21548331_2020_1754687 crossref_primary_10_1016_j_ddmod_2011_12_002 crossref_primary_10_3389_fmicb_2020_584812 crossref_primary_10_1177_1753466619885529 crossref_primary_10_1128_AAC_00490_18 crossref_primary_10_1177_10600280231201953 crossref_primary_10_1038_srep30427 crossref_primary_10_1093_cid_ciu219 crossref_primary_10_1093_cid_cix726 crossref_primary_10_1513_AnnalsATS_201902_162OC crossref_primary_10_14260_jemds_571 crossref_primary_10_1016_j_cbi_2022_110050 crossref_primary_10_1093_jac_dkq335 crossref_primary_10_3389_fmicb_2022_987656 crossref_primary_10_3390_antibiotics11040474 crossref_primary_10_1016_j_ijantimicag_2020_106022 crossref_primary_10_3109_1547691X_2013_839587 crossref_primary_10_1128_AAC_01699_18 crossref_primary_10_1016_j_pneumo_2013_02_005 crossref_primary_10_1128_spectrum_02340_21 crossref_primary_10_3390_antibiotics9020094 crossref_primary_10_1089_mdr_2015_0220 crossref_primary_10_1146_annurev_physiol_021014_071937 crossref_primary_10_7759_cureus_11327 crossref_primary_10_3389_fmicb_2016_01260 crossref_primary_10_1097_MCC_0b013e3283577d37 crossref_primary_10_12688_f1000research_129080_2 crossref_primary_10_12688_f1000research_129080_1 crossref_primary_10_3389_fmicb_2020_01718 crossref_primary_10_5812_jjm_23569 crossref_primary_10_1371_journal_pone_0159694 crossref_primary_10_1159_000488953 crossref_primary_10_1371_journal_ppat_1003576 crossref_primary_10_1016_j_tim_2016_09_007 crossref_primary_10_1007_s10388_021_00834_0 crossref_primary_10_1586_erm_12_53 crossref_primary_10_1016_j_ajic_2013_04_009 crossref_primary_10_1016_j_ijantimicag_2018_04_011 crossref_primary_10_1007_s10989_023_10511_8 crossref_primary_10_1088_1752_7155_9_1_016004 crossref_primary_10_1172_jci_insight_98178 crossref_primary_10_4155_cli_12_86 crossref_primary_10_1016_j_eimc_2013_04_014 crossref_primary_10_1371_journal_pone_0109072 crossref_primary_10_1086_664763 crossref_primary_10_7759_cureus_38858 crossref_primary_10_1186_s12879_016_1942_z crossref_primary_10_32322_jhsm_457420 crossref_primary_10_1038_s41598_017_03656_2 crossref_primary_10_3389_fcimb_2018_00107 crossref_primary_10_1097_SHK_0000000000001288 crossref_primary_10_1007_s10096_016_2833_3 crossref_primary_10_1093_jac_dkz371 crossref_primary_10_3390_antibiotics11101411 crossref_primary_10_3390_antibiotics12020367 crossref_primary_10_1016_j_diagmicrobio_2012_07_001 crossref_primary_10_1016_j_jiac_2019_08_018 crossref_primary_10_3389_fcimb_2024_1503892 crossref_primary_10_1007_s00005_018_0510_1 crossref_primary_10_1016_j_jbc_2022_102487 crossref_primary_10_1186_s13054_021_03694_3 crossref_primary_10_1093_jacamr_dlae001 crossref_primary_10_1152_ajplung_00078_2016 crossref_primary_10_1111_ajt_15488 crossref_primary_10_1172_JCI97065 crossref_primary_10_1016_j_jhin_2019_06_005 crossref_primary_10_1097_MCP_0000000000000957 crossref_primary_10_1149_1945_7111_ac1893 crossref_primary_10_1097_CM9_0000000000000368 crossref_primary_10_1097_MCC_0000000000000526 crossref_primary_10_1016_j_peptides_2013_02_001 crossref_primary_10_1111_tid_12471 crossref_primary_10_1016_j_jinf_2019_11_021 crossref_primary_10_1128_IAI_05114_11 crossref_primary_10_1128_spectrum_01690_22 crossref_primary_10_1016_j_diagmicrobio_2012_08_010 crossref_primary_10_1093_cid_ciab776 crossref_primary_10_3389_fmed_2023_1295277 crossref_primary_10_1136_bmjopen_2021_050105 crossref_primary_10_1016_j_diagmicrobio_2020_115172 crossref_primary_10_1128_AAC_05354_11 crossref_primary_10_1016_j_ijantimicag_2012_08_004 crossref_primary_10_3389_fmicb_2015_00893 crossref_primary_10_1186_s12866_021_02102_8 crossref_primary_10_3389_fcimb_2018_00205 crossref_primary_10_1080_14656566_2020_1840552 crossref_primary_10_1186_s13756_019_0518_2 crossref_primary_10_1038_ncomms13944 crossref_primary_10_1016_j_ijantimicag_2018_09_008 crossref_primary_10_1097_MCP_0b013e328351f974 crossref_primary_10_1155_2012_843509 crossref_primary_10_1099_jmm_0_001350 crossref_primary_10_1097_IPC_0b013e31829e69d4 crossref_primary_10_1007_s13546_012_0472_y crossref_primary_10_1128_JCM_01028_14 crossref_primary_10_1016_j_jiac_2018_02_011 crossref_primary_10_1620_tjem_242_9 crossref_primary_10_1002_jcph_2165 crossref_primary_10_36106_gjra_4501871 crossref_primary_10_1007_s00284_020_01974_9 crossref_primary_10_1128_MRA_00422_19 crossref_primary_10_1016_j_ijantimicag_2014_01_007 crossref_primary_10_1517_17425255_2013_788150 crossref_primary_10_1016_j_bjid_2016_09_008 crossref_primary_10_1186_cc9604 crossref_primary_10_1016_j_jhin_2011_11_013 crossref_primary_10_1016_j_pupt_2023_102259 crossref_primary_10_1097_MCC_0000000000000231 crossref_primary_10_1093_femsre_fuy045 crossref_primary_10_3389_fped_2019_00380 crossref_primary_10_1007_s40262_016_0418_z crossref_primary_10_1016_j_chest_2020_06_034 crossref_primary_10_1016_j_bbrc_2017_05_022 crossref_primary_10_1097_MJT_0000000000000878 crossref_primary_10_1186_s12879_019_4660_5 crossref_primary_10_1016_j_suc_2014_08_002 crossref_primary_10_1007_s12559_020_09787_5 crossref_primary_10_1016_j_medin_2016_01_007 crossref_primary_10_5492_wjccm_v12_i3_165 crossref_primary_10_1016_j_diagmicrobio_2013_08_011 crossref_primary_10_1016_j_job_2013_06_004 crossref_primary_10_1128_aac_00239_22 crossref_primary_10_1128_spectrum_01829_22 crossref_primary_10_5812_jjm_111997 crossref_primary_10_1093_jac_dkx144 crossref_primary_10_1080_17425255_2023_2178896 crossref_primary_10_1128_AAC_02564_18 crossref_primary_10_1136_bcr_2015_212872 crossref_primary_10_22207_JPAM_12_4_69 crossref_primary_10_3390_ijerph18084358 crossref_primary_10_1016_j_ccm_2018_08_006 crossref_primary_10_1038_mi_2012_62 crossref_primary_10_1128_CMR_00101_15 crossref_primary_10_1002_pds_3614 crossref_primary_10_1111_resp_12651 crossref_primary_10_1128_JB_00286_11 crossref_primary_10_24018_ejmed_2023_5_4_1801 crossref_primary_10_1099_mgen_0_000519 crossref_primary_10_1371_journal_pone_0247013 crossref_primary_10_1128_AAC_00318_19 crossref_primary_10_3892_etm_2018_5904 crossref_primary_10_1016_j_xcrm_2021_100229 crossref_primary_10_1071_MA17046 crossref_primary_10_1038_s41598_022_18189_6 crossref_primary_10_1128_AAC_02643_14 crossref_primary_10_1177_0023677215575864 crossref_primary_10_1186_s13756_020_00819_1 crossref_primary_10_1097_IPC_0b013e318282630e crossref_primary_10_1016_j_diagmicrobio_2019_114884 crossref_primary_10_5005_jaypee_journals_10071_24667_226 crossref_primary_10_1093_cid_ciw353 crossref_primary_10_1016_j_rppnen_2014_01_003 crossref_primary_10_1016_j_med_2022_10_012 crossref_primary_10_15252_embr_202050348 crossref_primary_10_1128_CMR_00134_14 crossref_primary_10_3947_ic_2024_0060 crossref_primary_10_1128_aac_01399_21 crossref_primary_10_1097_CPM_0000000000000152 crossref_primary_10_1164_rccm_201102_0349OC crossref_primary_10_3389_fcimb_2016_00037 crossref_primary_10_14814_phy2_13491 crossref_primary_10_1093_cid_ciw245 crossref_primary_10_1016_j_jfma_2023_08_022 crossref_primary_10_1007_s11033_018_4515_y crossref_primary_10_1016_j_jhin_2016_04_011 crossref_primary_10_1016_j_ccm_2011_05_006 crossref_primary_10_1002_9780471729259_mc06f02s37 crossref_primary_10_1007_s11606_013_2649_0 crossref_primary_10_1099_jmm_0_000884 crossref_primary_10_4049_jimmunol_1103196 crossref_primary_10_1097_IPC_0000000000000360 crossref_primary_10_1007_s00228_019_02804_z crossref_primary_10_1093_ofid_ofac095 crossref_primary_10_4046_trd_2012_73_2_77 crossref_primary_10_2217_fmb_15_115 crossref_primary_10_1128_AAC_02187_18 crossref_primary_10_1016_j_jinf_2020_05_046 crossref_primary_10_1186_s12941_021_00468_1 crossref_primary_10_2147_IDR_S404786 crossref_primary_10_1007_s40266_023_01052_2 crossref_primary_10_1016_j_ejcdt_2013_11_012 crossref_primary_10_1002_14651858_CD013864_pub2 crossref_primary_10_1016_j_ccc_2013_03_007 crossref_primary_10_3390_proteomes4010011 crossref_primary_10_22627_2072_8107_2018_17_3_62_63 crossref_primary_10_1172_jci_insight_150813 crossref_primary_10_1007_s00436_017_5435_9 crossref_primary_10_3390_jcm9113508 crossref_primary_10_1016_j_intimp_2014_10_027 crossref_primary_10_1016_j_ijantimicag_2021_106491 crossref_primary_10_1016_j_chest_2017_04_162 crossref_primary_10_1017_ice_2021_229 crossref_primary_10_2147_IDR_S313828 crossref_primary_10_3390_medicina59061058 crossref_primary_10_1371_journal_ppat_1009491 crossref_primary_10_3390_biomedicines11030971 crossref_primary_10_1016_S2222_1808_14_60630_7 crossref_primary_10_1007_s10875_020_00919_y crossref_primary_10_1371_journal_pone_0150909 crossref_primary_10_1016_j_ijantimicag_2014_01_032 crossref_primary_10_2903_j_efsa_2016_4522 crossref_primary_10_1128_CMR_00019_11 crossref_primary_10_3390_cells12010199 crossref_primary_10_1093_infdis_jiv301 crossref_primary_10_1080_09603123_2023_2280149 crossref_primary_10_2147_IDR_S236026 crossref_primary_10_3390_antibiotics11030359 crossref_primary_10_1016_j_jhin_2013_07_008 crossref_primary_10_1016_j_acci_2020_12_002 |
| ContentType | Journal Article Conference Proceeding |
| Copyright | 2010 Infectious Diseases Society of America 2015 INIST-CNRS Copyright University of Chicago, acting through its Press Aug 1, 2010 |
| Copyright_xml | – notice: 2010 Infectious Diseases Society of America – notice: 2015 INIST-CNRS – notice: Copyright University of Chicago, acting through its Press Aug 1, 2010 |
| DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QL 7T2 7T7 7U7 7U9 8FD C1K FR3 H94 K9. M7N P64 7X8 |
| DOI | 10.1086/653053 |
| DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Health and Safety Science Abstracts (Full archive) Industrial and Applied Microbiology Abstracts (Microbiology A) Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Toxicology Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Safety Science Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | Virology and AIDS Abstracts MEDLINE Engineering Research Database MEDLINE - Academic Engineering Research Database |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Geography |
| EISSN | 1537-6591 |
| EndPage | S87 |
| ExternalDocumentID | 2078290301 20597676 23037658 10_1086_653053 20750760 ark_67375_HXZ_XX6TRHSP_3 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review Feature |
| GroupedDBID | --- ..I .2P .I3 .ZR 08P 0R~ 1TH 29B 2AX 2WC 36B 4.4 48X 53G 5GY 5RE 5VS 5WD 6J9 AABZA AACGO AACZT AAJKP AAJQQ AAMVS AANCE AAOGV AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP ABBHK ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABLJU ABNGD ABNHQ ABOCM ABPLY ABPQP ABPTD ABQLI ABQNK ABTLG ABVGC ABWST ABXSQ ABXVV ACGFO ACGFS ACHIC ACPRK ACUFI ACUKT ACUTJ ACUTO ACYHN ADBBV ADGZP ADHKW ADHZD ADIPN ADNBA ADQBN ADQXQ ADRTK ADULT ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEUPB AEWNT AEXZC AFFNX AFFZL AFIYH AFOFC AFRAH AFXAL AGINJ AGQPQ AGQXC AGSYK AGUTN AHMBA AHMMS AHXPO AIAGR AJBYB AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN AQKUS AQVQM ASPBG ATGXG AVWKF AXUDD AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BSCLL BTRTY BVRKM C1A C45 CDBKE CS3 CZ4 DAKXR DCCCD DIK DILTD DU5 D~K E3Z EBS EE~ EJD EMOBN ENERS F5P F9B FECEO FEDTE FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC H13 H5~ HAR HVGLF HW0 HZ~ IOX IPSME J21 JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST JXSIZ KAQDR KBUDW KOP KSI KSN L7B MHKGH MJL ML0 N4W N9A NGC NOMLY NOYVH NU- NVLIB O0~ O9- OAUYM OAWHX OCZFY ODMLO ODZKP OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD RD5 ROX ROZ RUSNO RW1 RXO SA0 SJN TCURE TEORI TJX TMA TR2 W8F X7H YAYTL YKOAZ YXANX ~91 ~S- AAYOK AGORE .GJ 1KJ 3O- 70D AAPGJ AAPNW AAWDT AAYXX ABKDP ABNKS ABSMQ ABZBJ ACFRR ACPQN ACVCV ACZBC ADEYI ADMTO ADOCK AEKPW AFFQV AFSHK AFYAG AGKEF AGKRT AGMDO AHGBF AI. AIJHB AJDVS APJGH AQDSO AVNTJ BZKNY CITATION EIHJH HQ3 HTVGU J5H MBLQV OBFPC O~Y VH1 Y6R ZGI IQODW CGR CUY CVF ECM EIF M49 NPM 7QL 7T2 7T7 7U7 7U9 8FD C1K FR3 H94 K9. M7N P64 7X8 |
| ID | FETCH-LOGICAL-c557t-49a9229663e1cae6aba7b08a6d86937b1798f4c3273727089e5fdaf8d9ddf0743 |
| ISSN | 1058-4838 1537-6591 |
| IngestDate | Fri Sep 05 00:41:41 EDT 2025 Fri Sep 05 04:09:19 EDT 2025 Fri Sep 05 04:08:19 EDT 2025 Fri Jul 25 08:03:08 EDT 2025 Thu Apr 03 07:09:35 EDT 2025 Mon Jul 21 09:16:54 EDT 2025 Thu Apr 24 22:57:07 EDT 2025 Tue Jul 01 01:25:47 EDT 2025 Thu Jun 19 15:34:18 EDT 2025 Sat Sep 20 11:02:26 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | Supplement-1 |
| Keywords | Lung disease Nosocomial infection Artificial ventilation Respiratory disease Etiology Bacterial pneumonia |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MeetingName | Workshop on Issues in the Design of Clinical Trials for Antibacterial Drugs for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia |
| MergedId | FETCHMERGED-LOGICAL-c557t-49a9229663e1cae6aba7b08a6d86937b1798f4c3273727089e5fdaf8d9ddf0743 |
| Notes | ark:/67375/HXZ-XX6TRHSP-3 istex:FE78D891B873DD60750630CEE361337871CDBA9E SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 ObjectType-Article-2 |
| OpenAccessLink | https://academic.oup.com/cid/article-pdf/51/Supplement_1/S81/20910471/51-Supplement_1-S81.pdf |
| PMID | 20597676 |
| PQID | 607254392 |
| PQPubID | 23462 |
| ParticipantIDs | proquest_miscellaneous_904493181 proquest_miscellaneous_904481892 proquest_miscellaneous_749022546 proquest_journals_607254392 pubmed_primary_20597676 pascalfrancis_primary_23037658 crossref_primary_10_1086_653053 crossref_citationtrail_10_1086_653053 jstor_primary_20750760 istex_primary_ark_67375_HXZ_XX6TRHSP_3 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2010-08-01 |
| PublicationDateYYYYMMDD | 2010-08-01 |
| PublicationDate_xml | – month: 08 year: 2010 text: 2010-08-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Oxford |
| PublicationPlace_xml | – name: Oxford – name: United States |
| PublicationTitle | Clinical infectious diseases |
| PublicationTitleAlternate | Clinical Infectious Diseases |
| PublicationYear | 2010 |
| Publisher | The University of Chicago Press University of Chicago Press Oxford University Press |
| Publisher_xml | – name: The University of Chicago Press – name: University of Chicago Press – name: Oxford University Press |
| References | Clin Infect Dis. 2010 Nov 1;51(9):1114 |
| References_xml | – reference: - Clin Infect Dis. 2010 Nov 1;51(9):1114 |
| SSID | ssj0011805 |
| Score | 2.5319848 |
| SecondaryResourceType | review_article |
| Snippet | Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) can be caused by a wide variety of bacteria that originate... |
| SourceID | proquest pubmed pascalfrancis crossref jstor istex |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | S81 |
| SubjectTerms | Acinetobacter Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antimicrobial agents Antimicrobials Bacteria - classification Bacteria - drug effects Bacteria - isolation & purification Bacterial diseases Bacterial diseases of the respiratory system Bacterial pneumonia Biological and medical sciences Clinical trials Cross Infection - drug therapy Cross Infection - epidemiology Cross Infection - microbiology Drug resistance Drug Resistance, Bacterial Drugs Enterobacter Escherichia coli Etiology General aspects Geography Gram-negative bacilli Gram-negative bacteria Haemophilus influenzae Hospitals Human bacterial diseases Human infectious diseases. Experimental studies and models Humans Incidence Infectious diseases Klebsiella Medical sciences Nosocomial infections Pathogens Patient surveillance Pharmacology Pneumonia Pneumonia, Bacterial - drug therapy Pneumonia, Bacterial - epidemiology Pneumonia, Bacterial - microbiology Pneumonia, Ventilator-Associated - drug therapy Pneumonia, Ventilator-Associated - epidemiology Pneumonia, Ventilator-Associated - microbiology Pseudomonas aeruginosa Reviews Serratia Staphylococcus aureus Stenotrophomonas maltophilia Ventilator associated pneumonia |
| Title | Microbial Etiologies of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia |
| URI | https://api.istex.fr/ark:/67375/HXZ-XX6TRHSP-3/fulltext.pdf https://www.jstor.org/stable/20750760 https://www.ncbi.nlm.nih.gov/pubmed/20597676 https://www.proquest.com/docview/607254392 https://www.proquest.com/docview/749022546 https://www.proquest.com/docview/904481892 https://www.proquest.com/docview/904493181 |
| Volume | 51 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaglRA3Hi2EQskBuKCgxPEjPkIpWkBbVnSLIi6R48RS1SpF3ayE-PWMndhJ2bQILtEqGWXX-3nGY883Mwi9wDWrUiGrKJGJiojCYAdZoiMtOLj3SSzKyiQ4z4_Y7IR8ymnuesn32SVt-Ub9mswr-R9U4R7garJk_wFZ_1K4AZ8BX7gCwnDdxHhyqTlwiY2OVLVeuZjLajwb5qe24JIpItzaBJXTrtisaxsSvVWGEgze57uufDNILpp6DUPpsrZefzO0onOzRY8cpNPSnpPz5ejwuCNvm-PnPubTHzCM6G3tTYmLI5sZU3smmY2NaldFdsM-xzZcxChYmXRYgVzU_Y-FydMFYZsEdpBmt9E2TnlmOnS8__jZB4uSzDJV_e8YtZDqvumKz7Ft1Oeno58aLqxcAU6662Ny_UbDOhzLe2hnSMUMFx75--hW3TxAd-Y9I-IhOvPIhgOy4YUON5ANPVahxyoEZMNJZKekd9DJh8PlwSzqG2hEilLeRkRIgTFsaNM6UbJmspS8jDPJqoyBW1qaYnWaqBSbXkU8zkRNdSV1Vomq0sa33EVbzUVTP0ahxqlWirA00YyA4gtCY4mFae9aKnCiA_TS_cWF6qvLmyYn54VlOWSs6KAI0HMv96Orp7Ih8coi5B_LyzPDPuS0mOXfizxny6-z40UBgrsWQi-IjfvLWRyg_SuYDgL9PArQngO56NV5VbCYm8IQAgco9E_B1poAmmxq0N-CEwEuLyXsehEREwI-8E1vMSICltIkQI-6CTYaAezvGWdP_jaCPXR3UNWnaKu9XNfPwDtuy32rG78BdbW-eg |
| linkProvider | Flying Publisher |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=proceeding&rft.title=Clinical+infectious+diseases&rft.atitle=Microbial+Etiologies+of+Hospital-Acquired+Bacterial+Pneumonia+and+Ventilator-Associated+Bacterial+Pneumonia&rft.au=JONES%2C+Ronald+N&rft.date=2010-08-01&rft.pub=Oxford+University+Press&rft.issn=1058-4838&rft.volume=51&rft_id=info:doi/10.1086%2F653053&rft.externalDBID=n%2Fa&rft.externalDocID=23037658 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1058-4838&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1058-4838&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1058-4838&client=summon |